[Federal Register Volume 84, Number 246 (Monday, December 23, 2019)]
[Notices]
[Pages 70555-70556]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-20-1186; Docket No. CDC-2019-0098]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Information Collection for
Tuberculosis Data from Referring Entities to CureTB, which enables CDC
to coordinate continuity of care services for individuals with
tuberculosis.
DATES: CDC must receive written comments on or before February 21,
2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0098 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, of the Information
Collection Review Office, Centers for Disease Control and Prevention,
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
[[Page 70556]]
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Information Collection for Tuberculosis Data from Referring
Entities to CureTB (OMB Control No. 0920-1186, Exp. 06/30/2020)--
Revision--National Center for Emerging Zoonotic and Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CureTB at the Centers for Disease Control and Prevention (CDC),
works with domestic and international programs to protect the U.S.
public by preventing TB disease transmission domestically and
internationally, as well as preventing the development of drug
resistant TB. These goals are accomplished through CureTB referral and
continuity of care services for mobile TB patients.
Lack of treatment adherence and inappropriate selection of
medications are prime reasons for the continued emergence and spread of
resistant strains of tuberculosis. To combat this, CureTB ensures that
patients understand how to remain adherent to treatment regimens,
despite moving between nations. CureTB also provides information to the
health care team that will be continuing care about each patient's TB
strain and tailored medication regimen. CureTB gathers demographic and
clinical information for each patient and connects that individual to
appropriate clinical care. This information is also provided on a real-
time basis to medical providers and public health authorities in
receiving nations so follow-up with the patient can be expedited.
The respondents for the CureTB referral services are nurse
practitioners, registered nurses, and physicians working for
organizations within the United States and other countries who provide
diagnostic and treatment services to individuals affected by TB. The
organizations are primarily state and local health departments, but
include immigration detention centers, correctional facilities, and
foreign national TB programs. All 50 U.S. states and territories may
refer TB patients to the CureTB program. To date, CureTB has also
received referrals from Mexico and Guatemala.
Registered nurses or nurse practitioners will submit CureTB
referral forms as they request referral services. The number of
referrals varies widely between respondents. To ensure adequate
referral to treatment occurs, CDC CureTB may need to follow-up with an
individual to complete missing data fields concerning clinical or
contact information. This is done to ensure continuity of care.
Therefore, individuals with TB are also respondents in this information
collection. CDC's CureTB program will also continue working with our
public health partners in notifications and referrals for contacts of
TB cases. This is a lesser used function of CureTB, but burden is
included below. These respondents are registered nurses or nurse
practitioners working in health departments.
Finally, CDC staff in the CureTB program also contact the new
treating physicians to determine patient outcomes using CureTB
Clinician Public Health Department Follow-up Script. The physicians are
generally contacted every two months over the course of standard six
month TB treatment, for a total of three follow-up contacts per
patient. There are no costs to respondents other than the time required
to complete the referral documents and respond to CDC requests for TB
patient outcomes. The total burden requested is 1,117 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Registered Nurses/Nurse CureTB 100 3 30/60 150
Practitioners. Transnational
Notification.
TB patients.................. CureTB 200 1 5/60 17
Transnational
Notification.
TB patients (ICE referrals).. CureTB 600 1 45/60 450
Transnational
Notification.
TB treating physicians....... Clinician Public 900 3 10/60 450
Health
Department
Follow-up Script.
Registered Nurses/Nurse CureTB Contact/ 20 5 30/60 50
Practitioners. Source
Investigation
(CI/SI)
Notification.
---------------------------------------------------------------
Total.................... ................. .............. .............. .............. 1,117
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-27559 Filed 12-20-19; 8:45 am]
BILLING CODE 4163-18-P